Stefaan De Smedt

Stefaan De Smedt profile picture


Prof. Dr. Stefaan C. De Smedt
Pro-dean of the faculty of Pharmaceutical Sciences
Director of Ghent Research Group on Nanomedicines
Director of Laboratory of General Biochemistry and Physical Pharmacy
Editor (for Europe, Middle East & Africa) of the Journal of Controlled Release

Ghent University
Ottergemsesteenweg 460
9000 Gent
Tel: 0032 9 2648047 (secretary)
Tel: 0032 9 264 8076 (direct)
Fax: 0032 9 2648189


Stefaan C. De Smedt  (°1967; Belgium) studied pharmacy and graduated from Ghent University in 1995. He joined the pharmaceutical development group of Janssen Research Foundation (1995-97). Following post-doctoral research at the Departments of Pharmacy in Ghent and Utrecht he became Professor in Physical Pharmacy and Biopharmacy at Ghent University (1999) where he founded the Ghent Research Group on Nanomedicines. He served as Guest Professor at KU-Leuven, U-Antwerp and Shanghai Jiao Tong University. Currently he is a Specially Appointed Professor of Nanjing Forestry University. He served as dean of his faculty in Ghent (2010-2014) and is currently a member of the Board of Directors of Ghent University. In 2015 he has been elected as member of the Belgian Royal Academy of Medicine. Since 2004 Dr. De Smedt serves as the European Associate Editor of the Journal of Controlled Release (JCR); In 2015 he became Editor of JCR for the region Europe- the Middle East & Africa.

Dr. S.C. De Smedt initiated research on nanomedicines at Ghent University. He explores the interface between drug delivery, biophysics, material sciences and physical chemistry. Dr. De Smedt is the author or co-author of about 290 manuscripts (articles, reviews and proceedings; h-index 61; > 13000 citations) including contributions to Nature Materials, Nature Communications, Nature biotechnology, Nature Drug Discovery Reviews and Nano Letters. He has been the scientific promoter and mentor of 41 defended doctoral thesis’s; Eight of his fellows are full professors at various faculties in Belgium and abroad.  Dr. S.C. De Smedt received the Scott Blair Biorheology Award for his Ph.D work; For his research on drug delivery he received the Controlled Release Society Young Investigator Award 2006 (Vienna) and the APV Research Award 2010 for Outstanding Research Achievements in Pharmaceutical Sciences (Malta). In 2016 he and his co-worker Dr. Koen Raemdonck received the T. Nagai Research Achievement Award (Seattle, US). In 2017 he was awarded as Distinguished Scientist of the Chinese Academy of Sciences  (Hefei, China).

Dr. Stefaan De Smedt filed 18 patents on carriers (and adjuvants) for drug delivery, and materials (and methods) for diagnostics.  He is a scientific founder of Memobead Technologies, a spin-off from Ghent University, whose technology was further developed by Biocartis in Lausanne (Swiss) and Mechelen (Belgium). Currently MyCartis (Ghent) commercializes the technology.